# T4N5 Liposome Lotion Compared With Placebo Lotion for Preventing Actinic Keratoses in Patients With Xeroderma Pigmentosum

> **NCT00002811** · PHASE3 · UNKNOWN · sponsor: **Applied Genetics** · enrollment: 30 (estimated)

## Conditions studied

- Precancerous Condition

## Interventions

- **DRUG:** liposomal T4N5 lotion

## Key facts

- **NCT ID:** NCT00002811
- **Lead sponsor:** Applied Genetics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1996-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2013-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002811, "T4N5 Liposome Lotion Compared With Placebo Lotion for Preventing Actinic Keratoses in Patients With Xeroderma Pigmentosum". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00002811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*